News | March 27, 2013

Vascular Solutions Recalls Guardian II Hemostasis Valves

Class I recall due to risk of air being introduced into device

Guardian II Hemostais Valve, recall

March 27, 2013 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of the Vascular Solutions Inc. Guardian II and Guardian II NC Hemostasis Valves, model numbers 8210, 8211, 8215 and 8216. The firm is recalling the product due to a risk that air may be introduced into the device, which may lead to an air embolism. This product may cause serious adverse health consequences, including death.

A list of the recalled lot numbers is available from Vascular Solutions and has been provided to each facility that purchased the affected products. The recalled products were manufactured and distributed from February 2012 to February 2013.

The Guardian II and Guardian II NC hemostasis valves are intended to reduce blood loss during catheterization procedures.

On Feb. 28, 2013, Vascular Solutions sent an urgent medical device recall letter to its customers. The letter described the problem and the product involved in the recall. The firm advised its customers to immediately remove the recalled product from their inventory and secure it.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

For more information:



Related Content

nanoparticles, blood clotting, internal bleeding, American Chemical Society study, Erin B. Lavik

Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.

News | Hemostasis Management | August 24, 2016
August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...
News | Hemostasis Management | January 06, 2016
The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries...
Overlay Init